CORMEDIX INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

On January 21, 2021, CorMedix Inc. (the "Company") announced that it has been approved for listing on the Nasdaq Global Market ("Nasdaq") under its current symbol "CRMD". The Company expects that its common stock will begin trading on Nasdaq on February 2, 2021.

Also on January 21, 2021, the Company informed the NYSE American (the "NYSE") that it intended to transfer its listing to Nasdaq. The Company's shares of common stock will continue to trade on the NYSE American until the close of the market on February 1, 2021.

A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits



Exhibit No.   Description

99.1            Press release dated January 21, 2021




                                       1

© Edgar Online, source Glimpses